Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels
The cognitively operated system is a mother patent invention, first launched in India
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Subscribe To Our Newsletter & Stay Updated
